In addition, OLT1177 reduced cytokine release in mononuclear cells isolated from patients with CAPS, in which constitutive active mutants of NLRP3 spontaneously release IL-1β and IL-18 in the absence of tissue damage or infection [100]. Here, NLRP3 is linked to infection.